Pay in 4 interest-free payments of $6.45 Learn more
Ships within 48 hours · Estimated delivery Oct 24 - Oct 29
Injectable healing protocol: 23 mg daily (upper end of range), systemic injection - not into the wound itself - daily until the wound resolves, plus 12 weeks maintenance Topical healing protocol: 2 %4 % in a wound-appropriate vehicle applied 23 times daily to wound margins (never into an open, actively bleeding wound) under clinician supervision Stacking: GHK-Cu pairs exceptionally well with BPC-157 and TB-500 - the so-called GLOW stack - for complex healing cases
Elevated dose: 3 mg of GHK-Cu + 600 mcg each of BPC-157, TB-4, KPV
The compound incorporates three non-standard structural features: an -aminoisobutyric acid (Aib) at the N-terminus bearing no stereocenter, a D-2-naphthylalanine (D-2-Nal) at position 3, and a D-phenylalanine at position 4
It worked in most, but given the weekly commitment with short term results, it was impractical for most
Ketolytic and glycolytic enzymatic expression profiles in malignant gliomas: implication for ketogenic diet therapy
US$ 29.13
US$ 28.51
US$ 24.53
